A randomized phase II study of cediranib (CED) alone versus CED plus dasatinib (DAS) in patients (pts) with castration-resistant prostate cancer (CRPC). Phase II trial of intravenous carboplatin (C), ...
The doctors and nurses at the emergency room in Jacksonville, Florida, were “perplexed,” as Dia Thomas remembers it. They believed her when she said she was in pain—imaging had revealed fractures in ...
A biopsy is the only test that can confirm a cancer diagnosis. However, before doctors conduct a biopsy, they may take a person’s medical history, perform a physical exam, and order various imaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results